# U-LABA/ICS Effects on Exercise Performance, Formoterol

> **NCT06105671** · NA · COMPLETED · sponsor: **Morten Hostrup, PhD** · enrollment: 20 (actual)

## Conditions studied

- Exercise Performance

## Interventions

- **DRUG:** Symbicort
- **DRUG:** Formoterol
- **DRUG:** Formoterol
- **DRUG:** Placebo
- **DRUG:** Mannitol

## Key facts

- **NCT ID:** NCT06105671
- **Lead sponsor:** Morten Hostrup, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-05
- **Primary completion:** 2024-07-04
- **Final completion:** 2024-07-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06105671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06105671, "U-LABA/ICS Effects on Exercise Performance, Formoterol". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06105671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*